Evidence map›Paper›PMID 36362762›Full record

ArticleJournal of clinical medicine2022

Effect of a 6-Week Cycle of Nordic Walking Training on Vitamin 25(OH)D

Olga Czerwińska-Ledwig, David H Vesole, Anna Piotrowska, Joanna Gradek, Wanda Pilch, Artur Jurczyszyn

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Exercise interventions in patients with multiple myeloma: a scoping review.BMC sports science, medicine & rehabilitation · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Olga Czerwińska-LedwigDepartment of Chemistry and Biochemistry, Institute of Basic Sciences, Faculty of Motor Rehabilitation, University of Physical Education in Kraków, 31-571 Krakow, Poland.ORCID 0000-0003-1855-1276
David H VesoleMyeloma Division, John Theurer Cancer, Center at Hackensack Meridian School of Medicine, Hackensack, NJ 07601, USA.
Anna PiotrowskaDepartment of Chemistry and Biochemistry, Institute of Basic Sciences, Faculty of Motor Rehabilitation, University of Physical Education in Kraków, 31-571 Krakow, Poland.ORCID 0000-0002-9535-173X
Joanna GradekDepartment of Athletics, Institute of Sports Sciences, Faculty of Physical Education and Sport, University of Physical Education in Kraków, 31-571 Krakow, Poland.ORCID 0000-0003-4429-1527
Wanda PilchDepartment of Chemistry and Biochemistry, Institute of Basic Sciences, Faculty of Motor Rehabilitation, University of Physical Education in Kraków, 31-571 Krakow, Poland.
Artur JurczyszynPlasma Cell Dyscrasia Center, Department of Hematology, Faculty of Medicine, Jagiellonian University Medical College, 31-501 Krakow, Poland.ORCID 0000-0001-9796-8365
University School of Physical Education in Kraków · PLHackensack University Medical Center · USJagiellonian University · PL

Funding

Ministry of Science and Higher Education 022/RID/2018/19
6 · The paper itself

Abstract

Introduction: Multiple myeloma (MM) is a hematological malignancy affecting older adults. One of the most common myeloma-defining events is the development of symptomatic lytic bone disease. The serum concentrations of calcium (Ca), inorganic phosphorus (P), and vitamin 25(OH)D3 in the serum reflect bone metabolism. An enzyme lactate dehydrogenase (LDH) is a marker of muscle damage, but its serum activity also has an important prognostic value in MM. Myoglobin (Mb) is a small protein present in muscles; its serum level increases when myocytes are damaged. Objectives: In this study, the impact of a 6-week Nordic walking (NW) exercise program on blood parameters related to calcium-phosphate metabolism and damage of skeletal muscles was assessed. Patients and methods: A total of 33 patients with MM in the remission stage, without cytostatic treatment, were allocated and randomly assigned to one of two groups: 17 in the training group (NW) and 16 in the control group (CG). All patients were supplemented per os with vitamin D3 and calcium carbonate daily and received zoledronic acid every 4 weeks (intravenous). Nordic walking training sessions took place 3 times a week for 6 weeks, 1 h each. Blood samples were drawn before and after the 6 weeks of training sessions to assess the serum concentrations of vitamin 25(OH)D3, P, Ca, Mb, and LDH. Results: Patients from the NW group showed a statistically significant decrease in mean serum myoglobin concentration (p = 0.018) and an increase in 25(OH)D3 (p < 0.001) and total Ca (p = 0.001) concentrations. There were no statistically significant changes in the results obtained in CG. Between groups, after 6 weeks, Mb serum concentration was significantly lower in NW (p = 0.041), and 25(OH)D3 was higher (p < 0.001) compared to CG. There was a correlation between the changes in myoglobin, phosphorus, 25(OH)D3, and Ca concentrations after 6 weeks. Conclusions: NW training is a safe and beneficial form of physical exercise for patients with MM without inducing muscle damage. NW performed outside improves serum vitamin 25(OH)D3 concentration.

Indexed as

calcium-phosphate metabolismmultiple myelomamuscle damagephysical activityvitamin D

Identifiers

PMID36362762
PMCPMC9656680
OpenAlexW4308200600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.